EMILY SHAFFER: Open Payments
NPI 1720698772 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 68 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $553 · 2025 $1,333
Food & beverage: $1,333
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $148 |
| Lilly USA, LLC | 8 | $144 |
| AstraZeneca Pharmaceuticals LP | 6 | $141 |
| GlaxoSmithKline, LLC. | 8 | $140 |
| ABBVIE INC. | 5 | $92 |
| Exact Sciences Corporation | 5 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $66 |
| Novo Nordisk Inc | 3 | $55 |
| Amgen Inc. | 3 | $53 |
Products named: NURTEC ODT, MOUNJARO, QULIPTA, Cologuard Collection Kit, CAPLYTA, TRELEGY ELLIPTA, XIFAXAN, FARXIGA.
Industry payments across KS — which companies pay providers there.
